ES2141081T3 - Nuevo aislado de hcv j-1. - Google Patents

Nuevo aislado de hcv j-1.

Info

Publication number
ES2141081T3
ES2141081T3 ES90310149T ES90310149T ES2141081T3 ES 2141081 T3 ES2141081 T3 ES 2141081T3 ES 90310149 T ES90310149 T ES 90310149T ES 90310149 T ES90310149 T ES 90310149T ES 2141081 T3 ES2141081 T3 ES 2141081T3
Authority
ES
Spain
Prior art keywords
new
hcv
isolated hcv
new isolated
insulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90310149T
Other languages
English (en)
Other versions
ES2141081T5 (es
Inventor
Tatsuo Miyamura
Izumu Saito
Michael Houghton
Amy J Weiner
Jang Han
Janice A Kolberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OYA AKIRA DR DIR GRAL NAT INST
Novartis Vaccines and Diagnostics Inc
Original Assignee
OYA AKIRA DR DIR GRAL NAT INST
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2141081(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by OYA AKIRA DR DIR GRAL NAT INST, Chiron Corp filed Critical OYA AKIRA DR DIR GRAL NAT INST
Publication of ES2141081T3 publication Critical patent/ES2141081T3/es
Application granted granted Critical
Publication of ES2141081T5 publication Critical patent/ES2141081T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

SE PRESENTAN DOS NUEVOS AISLAMIENTOS DEL VIRUS DE LA HEPATITIS C (HCV), J1 Y J7. ESTOS NUEVOS AISLAMIENTOS COMPRENDEN SECUENCIAS NUCLEOTIDAS Y DE AMINOACIDOS QUE SON DISTINTAS DEL PROTOTIPO DE AISLAMIENTO DEL HCV, HCV1. DE ESTA FORMA, J1 Y J7 SUMINISTRAN NUEVOS POLINUCLEOTIDOS Y POLIPEPTIDOS PARA SU USO EN DIAGNOSTICOS, PRODUCCION DE PROTEINA RECOMBINANTE Y DESARROLLO DE VACUNAS.
ES90310149T 1989-09-15 1990-09-17 Nuevo aislado de hcv j-1. Expired - Lifetime ES2141081T5 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40804589A 1989-09-15 1989-09-15
US408045 1989-09-15
US45614289A 1989-12-21 1989-12-21
US456142 1989-12-21

Publications (2)

Publication Number Publication Date
ES2141081T3 true ES2141081T3 (es) 2000-03-16
ES2141081T5 ES2141081T5 (es) 2009-12-11

Family

ID=27020120

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90310149T Expired - Lifetime ES2141081T5 (es) 1989-09-15 1990-09-17 Nuevo aislado de hcv j-1.

Country Status (11)

Country Link
EP (2) EP0419182B2 (es)
JP (3) JP3156200B2 (es)
AT (1) ATE188998T1 (es)
CA (1) CA2065287C (es)
DE (1) DE69033425T3 (es)
DK (1) DK0419182T4 (es)
ES (1) ES2141081T5 (es)
GR (1) GR3033100T3 (es)
IE (2) IE903363A1 (es)
PT (1) PT95329B (es)
WO (1) WO1991004262A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684594A5 (fr) 1989-12-18 1994-10-31 Wellcome Found Agent viral.
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
EP0527788B1 (en) * 1990-04-04 2004-06-30 Chiron Corporation Hepatitis c virus protease
JP3050395B2 (ja) * 1990-06-12 2000-06-12 国立感染症研究所長 Ｃ型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
US5747339A (en) 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
EP0469348B1 (en) * 1990-07-11 1997-03-12 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. cDNA sequence and detection of hepatits C virus
WO1992001714A1 (en) * 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Non-a non-b hepatitis virus antigen
DE59109221D1 (de) * 1990-11-03 2001-11-15 Dade Behring Marburg Gmbh HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (en) * 1991-04-10 1992-10-11 Hiroaki Okamoto Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
GB2272443B (en) 1991-06-10 1995-10-25 Lucky Ltd Nucleotide and amino acid sequences of Korean hepatitis C virus
RU2148587C1 (ru) * 1991-06-24 2000-05-10 Чирон Корпорейшн Полипептид и способ его получения, реагент для иммуноанализа, способ определения присутствия антител и способ индукции иммунного ответа
DE69233083T2 (de) * 1991-08-27 2003-12-18 Hoffmann La Roche Primers und Sondern zum Nachweis von Hepatitis C
DE69232859T2 (de) * 1991-09-13 2003-04-10 Chiron Corp Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
WO1993006247A1 (en) * 1991-09-16 1993-04-01 Abbott Laboratories Hepatitis c assay
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
MA22842A1 (fr) * 1992-03-27 1993-10-01 Smithkline Beecham Biolog Procede de preparation de compositions de vaccin.
US6433159B1 (en) 1992-09-10 2002-08-13 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of Hepatitis C virus associated diseases
US6174868B1 (en) 1992-09-10 2001-01-16 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
US6995146B2 (en) 1992-09-10 2006-02-07 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
US6391542B1 (en) 1992-09-10 2002-05-21 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of Hepatitis C virus-associated diseases
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
CA2662090A1 (en) 1993-04-27 1994-11-10 N.V. Innogenetics S.A. New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
ES2176342T5 (es) 1994-10-21 2010-02-09 Innogenetics N.V. Secuencias del genotipo 7 del virus de la hepatitis c y su utilizacion como agentes profilacticos, terapeuticos y de diagnosticos.
EP1178116A1 (en) * 2000-08-03 2002-02-06 Hybrigenics S.A. Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
EP2332574A1 (en) * 2000-08-17 2011-06-15 Tripep Ab HCV NS3/4A Sequences
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
JP2002125688A (ja) * 2000-10-30 2002-05-08 Tosoh Corp Ｃ型肝炎ウイルスの高感度検出のためのオリゴヌクレオチドおよび検出法
DE10112748A1 (de) * 2001-03-14 2002-09-19 Transmit Technologietransfer Erfindung betreffend HCV-Erkrankungen
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
EP1537418A2 (en) * 2002-09-13 2005-06-08 Intercell AG Method for isolating hepatitis c virus peptides
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
EP1716250B1 (en) 2004-01-07 2015-08-05 Third Wave Technologies, Inc. Determination of hepatitis c virus genotype
CN105697424B (zh) * 2016-01-19 2019-01-08 江苏大学 一种泵站用防旋涡装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
US4870026A (en) * 1982-09-16 1989-09-26 The General Hospital Corporation Non-A, non-B. hepatitis, virus, methods of identification purification, characterization, diagnosis and immunization
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
JP2590885B2 (ja) * 1987-03-31 1997-03-12 三菱化学株式会社 Ｄｎａ断片
JPH01124387A (ja) * 1987-11-10 1989-05-17 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎特異抗原をコードするｄｎａを有する発現ベクター、形質転換体および該抗原の産生方法
CA1339351C (en) 1987-10-15 1997-08-26 Michael S. Urdea Nucleic acid multimers and amplified nucleic acid hybridization assays using same
CN1074422C (zh) * 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法
JP2500880Y2 (ja) * 1988-05-02 1996-06-12 カシオ計算機株式会社 液晶表示装置
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
JPH0330676A (ja) * 1989-06-28 1991-02-08 Sanwa Kagaku Kenkyusho Co Ltd 非ａ非ｂ型肝炎ウイルスのｄｎａ、そのクローン及びこれらの調製法
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production

Also Published As

Publication number Publication date
DK0419182T4 (da) 2009-11-23
DE69033425T2 (de) 2000-06-08
JP3156200B2 (ja) 2001-04-16
EP0419182B1 (en) 2000-01-19
EP0419182B2 (en) 2009-07-22
EP0419182A1 (en) 1991-03-27
GR3033100T3 (en) 2000-08-31
WO1991004262A1 (en) 1991-04-04
JP2005143512A (ja) 2005-06-09
JPH09187285A (ja) 1997-07-22
CA2065287A1 (en) 1991-03-16
EP0939128A2 (en) 1999-09-01
DK0419182T3 (da) 2000-04-17
IE903363A1 (en) 1991-04-10
JPH05506773A (ja) 1993-10-07
ATE188998T1 (de) 2000-02-15
IE20020123A1 (en) 2003-05-28
DE69033425D1 (de) 2000-02-24
CA2065287C (en) 1999-12-21
EP0939128A3 (en) 2004-06-09
PT95329B (pt) 1998-04-30
DE69033425T3 (de) 2010-02-18
ES2141081T5 (es) 2009-12-11
PT95329A (pt) 1991-08-14

Similar Documents

Publication Publication Date Title
ES2141081T3 (es) Nuevo aislado de hcv j-1.
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
CY1115010T1 (el) ΕΝΑΣ ΜΟΛΥΣΜΑΤΙΚΟΣ cDNA ΚΛΩΝΟΣ ΤΟΥ ΙΟΥ ΤΟΥ ΧΟΙΡΕΙΟΥ ΑΝΑΠΑΡΑΓΩΓΙΚΟΥ ΚΑΙ ΑΝΑΠΝΕΥΣΤΙΚΟΥ ΣΥΝΔΡΟΜΟΥ ΒΟΡΕΙΟΥ ΑΜΕΡΙΚΗΣ (PRRS) ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
CO5590973A2 (es) Acido nucleico de adenovirus de simio y secuiencias de aminoacidos, vectores que contienen los mismos y metodos de uso
SE9004010D0 (sv) Viralt medel
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
ID29405A (id) Protein antigen tumor sart-3 yang baru dan peptida-peptida antigen tumornya
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
BR0114977A (pt) segmentos preferidos de proteìna de filamento neural e métodos para uso dos mesmos
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ATE208421T1 (de) Stimulierung der immunantwort durch virales protein
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DE69028658T2 (de) Proteine, Vakzine und Nucleinsäuren
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 419182

Country of ref document: ES